Our study suggests that m5C may play a critical role in the hypoxia-glycolysis network, and that the HIF-1α/ALYREF/PKM2 signaling pathway may be a potential therapeutic target for BLCA. The gene discussed is ALYREF; the disease is bladder transitional cell carcinoma.